FDA approves Lupin’s generic Topicort ointment

MUMBAI and BALTIMORE — The Food and Drug Administration has approved Lupin’s generic of Topicort (desoximetasone 0.25%) ointment, the company announced Tuesday. The drug is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

 

The drug had U.S. sales of $14.4 million for the 12 months ended September 2016.